Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects
S Lusvarghi, W Wang, R Herrup… - Journal of …, 2022 - Am Soc Microbiol
Mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical …
CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical …
[HTML][HTML] Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the …
S Lusvarghi, W Wang, R Herrup… - Journal of …, 2022 - ncbi.nlm.nih.gov
Mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical …
CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical …
[PDF][PDF] Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects
S Lusvarghi, W Wang, R Herrup, SN Neerukonda… - researchgate.net
Mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical …
CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical …
Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects
S Lusvarghi, W Wang, R Herrup… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical …
CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical …
Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects
S Lusvarghi, W Wang, R Herrup, SN Neerukonda… - 2021 - pesquisa.bvsalud.org
Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to
monoclonal antibodies, but other substitutions can modify the effects | PREPRINT-BIORXIV …
monoclonal antibodies, but other substitutions can modify the effects | PREPRINT-BIORXIV …
[HTML][HTML] Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects
S Lusvarghi, W Wang, R Herrup, SN Neerukonda… - 2021 - europepmc.org
Mutations in the spike protein of SARS-CoV-2 variants can compromise the effectiveness of
therapeutic antibodies. Most clinical-stage therapeutic antibodies target the spike receptor …
therapeutic antibodies. Most clinical-stage therapeutic antibodies target the spike receptor …
Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects
S Lusvarghi, W Wang, R Herrup, SN Neerukonda… - bioRxiv, 2021 - biorxiv.org
Mutations in the spike protein of SARS-CoV-2 variants can compromise the effectiveness of
therapeutic antibodies. Most clinical-stage therapeutic antibodies target the spike receptor …
therapeutic antibodies. Most clinical-stage therapeutic antibodies target the spike receptor …
Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects.
S Lusvarghi, W Wang, R Herrup… - Journal of …, 2021 - europepmc.org
Mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical …
CoV-2) variants can compromise the effectiveness of therapeutic antibodies. Most clinical …
Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects
S Lusvarghi, W Wang, R Herrup, SN Neerukonda… - bioRxiv, 2021 - biorxiv.org
Mutations in the spike protein of SARS-CoV-2 variants can compromise the effectiveness of
therapeutic antibodies. Most clinical-stage therapeutic antibodies target the spike receptor …
therapeutic antibodies. Most clinical-stage therapeutic antibodies target the spike receptor …